New York State Teachers Retirement System Has $2.88 Million Holdings in Progyny, Inc. (NASDAQ:PGNY)

New York State Teachers Retirement System lifted its holdings in Progyny, Inc. (NASDAQ:PGNY) by 0.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 77,434 shares of the company’s stock after acquiring an additional 500 shares during the quarter. New York State Teachers Retirement System owned approximately 0.08% of Progyny worth $2,879,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Millennium Management LLC grew its holdings in Progyny by 240.1% during the 4th quarter. Millennium Management LLC now owns 875,136 shares of the company’s stock worth $27,260,000 after acquiring an additional 617,830 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Progyny by 7.4% during the third quarter. Vanguard Group Inc. now owns 8,157,604 shares of the company’s stock worth $277,522,000 after acquiring an additional 565,160 shares during the last quarter. Jennison Associates LLC lifted its stake in shares of Progyny by 19.4% during the third quarter. Jennison Associates LLC now owns 2,706,454 shares of the company’s stock valued at $92,074,000 after acquiring an additional 438,932 shares during the period. Invesco Ltd. boosted its holdings in Progyny by 67.0% in the third quarter. Invesco Ltd. now owns 888,427 shares of the company’s stock valued at $30,224,000 after acquiring an additional 356,529 shares during the last quarter. Finally, BlackRock Inc. raised its holdings in Progyny by 3.8% during the 1st quarter. BlackRock Inc. now owns 9,700,353 shares of the company’s stock worth $311,575,000 after purchasing an additional 353,499 shares during the last quarter. 94.93% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Truist Financial dropped their price target on shares of Progyny from $47.00 to $46.00 and set a “buy” rating for the company in a research note on Wednesday, February 28th. Leerink Partnrs reaffirmed an “outperform” rating on shares of Progyny in a research note on Monday, February 26th. KeyCorp reduced their target price on Progyny from $45.00 to $43.00 and set an “overweight” rating on the stock in a report on Wednesday, February 28th. Barclays initiated coverage on shares of Progyny in a research note on Wednesday, January 3rd. They set an “overweight” rating and a $48.00 price objective on the stock. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $48.00 target price on shares of Progyny in a report on Wednesday, February 28th. Ten research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $48.30.

Insider Buying and Selling at Progyny

In other news, CFO Mark S. Livingston sold 11,165 shares of the firm’s stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $37.62, for a total transaction of $420,027.30. Following the completion of the transaction, the chief financial officer now directly owns 50,119 shares of the company’s stock, valued at approximately $1,885,476.78. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CFO Mark S. Livingston sold 11,165 shares of the stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $37.62, for a total transaction of $420,027.30. Following the completion of the transaction, the chief financial officer now directly owns 50,119 shares in the company, valued at approximately $1,885,476.78. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Chairman David J. Schlanger sold 1,000 shares of the firm’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $37.52, for a total value of $37,520.00. Following the completion of the transaction, the chairman now owns 83,631 shares of the company’s stock, valued at approximately $3,137,835.12. The disclosure for this sale can be found here. In the last quarter, insiders have sold 120,515 shares of company stock worth $4,570,131. Corporate insiders own 14.30% of the company’s stock.

Progyny Stock Down 1.1 %

Shares of NASDAQ:PGNY opened at $33.81 on Tuesday. The firm has a market cap of $3.26 billion, a price-to-earnings ratio of 54.53, a PEG ratio of 1.41 and a beta of 1.48. Progyny, Inc. has a 12 month low of $29.44 and a 12 month high of $44.95. The company’s fifty day simple moving average is $37.28 and its 200 day simple moving average is $35.71.

Progyny (NASDAQ:PGNY) last released its quarterly earnings results on Tuesday, February 27th. The company reported $0.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.04. The firm had revenue of $269.94 million for the quarter, compared to the consensus estimate of $274.08 million. Progyny had a return on equity of 12.64% and a net margin of 5.70%. The company’s revenue for the quarter was up 26.0% on a year-over-year basis. During the same quarter last year, the business posted $0.03 EPS. Research analysts expect that Progyny, Inc. will post 0.7 earnings per share for the current fiscal year.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.